PREVIOUS
✖
Dolutegravir - HIV Medicine
July 28 , 2019
1753 days
940
0
- The World Health Organisation has recommended the use of HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all populations.
- It is also recommended for pregnant women and those of childbearing potential.
- DTG is sold under the brand name Tivicay.
- It is an antiretroviral medication used together with other medications to treat HIV/AIDS.
- DTG is more effective, easier to take and has fewer side effects than alternative drugs.
- This drug also has a high genetic barrier to developing drug resistance.
Leave a Reply
Your Comment is awaiting moderation.